Insiders are masters of snatching up shares of their companies at a discount, expanding their positions during weakness in the stock.
Keep Reading →
June 18 - Insider Trading, Market Movers, News - Comments
The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers.
Keep Reading →
March 22 - News - Comments
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Keep Reading →
November 24 - News - Comments
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Keep Reading →
November 23 - News - Comments
Out of the 10 companies on this list, four are from Switzerland, while three are from Germany, reflective of the favorable position of the two countries in Europe’s economic...
Keep Reading →
April 17 - Earnings Report, Lists, News - Comments
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators.
Keep Reading →
April 5 - Lists, News - Comments
After recently getting the approval of the U.S.
Keep Reading →
March 16 - News, Stock Analysis - Comments
A Phase III study has shown that GP2017, which is manufactured by Sandoz, a unit of Novartis AG (ADR) (NYSE:NVS), has shown positive results as a Humira biosimilar.
Keep Reading →
March 8 - News, Stock Analysis - Comments
Novartis AG (ADR) (NYSE:NVS) has been fined approximately $174,000 in South Korea after the company was found guilty of bribing physicians in order to induce them to recommend...
Keep Reading →
March 3 - News, Stock Analysis - Comments
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Keep Reading →
February 23 - News, Stock Analysis - Comments
Novartis AG (ADR) (NYSE:NVS) is quickly entering into an engagement with the use of digital technology.
Keep Reading →
February 14 - News, Stock Analysis - Comments
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors ...
Keep Reading →
January 26 - Lists, News - Comments
Novartis AG (ADR) (NYSE:NVS) and Conatus Pharmaceuticals Inc (NASDAQ:CNAT) will jointly develop Conatus drug emricasan.
Keep Reading →
December 20 - News, Stock Analysis - Comments
Novartis AG (ADR) (NYSE:NVS) has recently acquired Selexys Pharmaceuticals Corp.
Keep Reading →
November 22 - News, Stock Analysis - Comments
Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109 as the Oldest Money Manager...
Keep Reading →
November 8 - Hedge Fund Analysis, Hedge Funds, News - Comments
Novartis AG (ADR) (NYSE:NVS) CDK4/6 breast cancer drug remains on track with Pfizer Inc. (NYSE:PFE)'s Ibrance.
Keep Reading →
November 2 - News - Comments
Novartis AG (ADR) (NYSE:NVS) just put out data from its multiple sclerosis (MS) trial, and it looks as if the company is winning the race to bring a drug to market that offers...
Keep Reading →
August 29 - News, Stock Analysis - Comments
Most individual investors invest in dividend-paying stocks to benefit from the steady streams of dividend checks, but can also take advantage of stock price appreciation as...
Keep Reading →
November 15 - Dividend Stocks, Hedge Fund Analysis, Hedge Funds, News - Comments
The shares of Chiasma Inc (NASDAQ:CHMA) are up by 25% on its first day of trading at $20.02 per share as of the time of writing.
Keep Reading →
July 16 - Hedge Funds, News - Comments
Is Apple Inc.
Keep Reading →
February 11 - News, Tech - Comments
GAMCO Investors and other funds managed by Mario Gabelli continue to aggressively add to their holdings in BioScrip Inc (NASDAQ:BIOS), having increased their position by another...
Keep Reading →
January 28 - Hedge Funds, News - Comments
In a discussion with Fox Business News anchors David Asman and Liz Claman from the show ‘After the bell,’ Hank Smith, who is the CIO of Haverford, speaks on his stock picks...
Keep Reading →
July 21 - News - Comments
In an interview with Bloomberg, Odile Rundquist, who is an analyst at Helvea, discusses on the second Qtr.
Keep Reading →
July 18 - Earnings Report, News - Comments
Rio Tinto plc (ADR) (NYSE:RIO), the world’s second-biggest mining company, is now seeing iron ore trading close to $100 per metric ton.
Keep Reading →
July 17 - News - Comments
In the financial world, there are many methods market participants can use to track the equity markets.
Keep Reading →
September 3 - News - Comments
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Keep Reading →
August 29 - News - Comments
The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc.
Keep Reading →
August 16 - News - Comments
Johnson & Johnson (NYSE:JNJ) stands alone as a leader across the major health-care industries.
Keep Reading →
June 27 - News - Comments
Pfizer Inc. (NYSE:PFE) was in 81 hedge funds' portfolio at the end of the first quarter of 2013. PFE shareholders have witnessed an increase in hedge fund interest recently.
Keep Reading →
June 24 - News - Comments
The Food and Drug Administration (FDA) made a groundbreaking policy change last year that is having a large impact on the biotech industry and creating a big opportunity for...
Keep Reading →
June 17 - Stock Analysis - Comments
If you'd ask most stock holders, hedge funds are assumed to be underperforming, outdated financial vehicles of yesteryear.
Keep Reading →
June 3 - News - Comments
Novartis AG (ADR) (NYSE:NVS) was in 24 hedge funds' portfolio at the end of March.
Keep Reading →
May 31 - News - Comments
To most investors, hedge funds are seen as slow, outdated financial vehicles of the past.
Keep Reading →
May 24 - News - Comments
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
Keep Reading →
May 6 - News - Comments
If you thought that the great run so far in 2013 was over for Biogen Idec Inc. (NASDAQ:BIIB), think again.
Keep Reading →
April 25 - News - Comments
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Keep Reading →
April 22 - News - Comments
Biogen Idec Inc.
Keep Reading →
April 17 - News - Comments
Johnson & Johnson (NYSE:JNJ) was in 67 hedge funds' portfolio at the end of December. JNJ has experienced a decrease in hedge fund interest in recent months.
Keep Reading →
April 8 - News - Comments
With interest rates still sitting near record lows, looking for current income have been forced to move away from fixed-income positions and into stocks to find yield.
Keep Reading →
March 15 - News - Comments